| No images? Click here  Thursday, 27 November 2025 MEDIA ADVISORY REMINDER UPDATED TOPIC: Virtual press conference on global health issues, with focus on launch of WHO guideline concerning glucagon-like peptide-1 (GLP-1) therapies and obesity in adults GLP-1 Guideline and related material embargoed until Monday, 1 December 2025, 14:45 CET / 13:45 GMT / 08:45 ET WHEN: 14.30 CET/13.30 GMT on Monday, 1 December 2025 Hosted by: Dr Tedros Adhanom Ghebreyesus, WHO Director-General Subjects: Launch of the first WHO guideline concerning GLP-1 therapies and obesity in adults, and other global health issues. The WHO GLP-1 Guideline is available under embargo to journalists only. To receive an embargoed copy of the Guideline and the accompanying press release, please contact Ms Jin Ni at jinn@who.int and Mr Paul Garwood at garwoodp@who.int, and please cc mediainquiries@who.int Embargo will lift at 14:45 CET / 13:45 GMT / 08:45 ET on Monday, 1 December 2025. Join via Zoom:
Join by phone:
Notes to journalists: Please enter your name and media outlet (use name/outlet) in your Zoom profile and ensure your microphone is connected and active on your computer. When you sign in, you will be automatically put in the meeting room. Click "raise hand" if you wish to ask a question (the icon can be found under the tab: participants), this will enter you into the queue for questions. Please note that only questions from the media are allowed during the press conference. The event will also be broadcast on WHO social media channels, and you can follow it there.  Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
Thursday, November 27, 2025
REMINDER - UPDATED TOPIC - Virtual press conference on global health issues, with focus on launch of WHO guideline concerning glucagon-like peptide-1 (GLP-1) therapies and obesity in adults
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment